Ariad Pharmaceuticals, Inc. Company Profile

Aggregated data from the web about Ariad Pharmaceuticals, Inc.

Company Name	Ariad Pharmaceuticals, Inc.
Website	https://en.wikipedia.org
Snippet	ARIAD Pharmaceuticals, Inc. was an American oncology company, now part of Takeda Oncology, which was founded in 1991 by Harvey J. Berger, M.D. and headquartered in Cambridge, Massachusetts.ARIAD engaged in the discovery, development, and commercialization of medicines for cancer patients. ARIAD’s most prominent drug discoveries include Iclusig, designed for patients with all forms of ...
Fate	Merged with Takeda Pharmaceuticals
Country	united states
Defunct	2017
Founded	1991
Revenue	US$118.8M (FY 2015)[1]
Website	www.ariad.com
Industry	Pharmaceuticals, biotechnology
Products	Ponatinib (FDA approved, trade name Iclusig)Ridaforolimus (FDA approved)Brigatinib (FDA approved)Rimiducid (Under development)AP32788 (Under development)
linkedin	linkedin.com/company/ariad-pharmaceuticals-inc-
Traded as	NASDAQ: ARIA
Key people	Harvey Berger,Founder, chairman, and CEO EmeritusAlex Denner,Chairman of the BoardTimothy P. Clackson,President of Research and Development and Chief Scientific Officer Ed Fitzgerald, (Former CFO)Marty Duvall, (Former CCO)
Net income	US$(231.16M) (FY 2015)[1]
size_range	51 - 200
Former type	Public
Headquarters	Cambridge, MA, United States
Total assets	US$546.69M (FY 2015)[1]
Operating income	US$(217.27M) (FY 2015)[1]
Number of employees	380 (2016)[2]

Ariad Pharmaceuticals, Inc. is part of the United States company list

Ariad Pharmaceuticals, Inc. is part of the Biotechnology company list

Ariad Pharmaceuticals, Inc. is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.